Skip to main content
TipRanks
Go Ultimate75% OFF

Santen Pharmaceutical Co (SNPHY) Q1 2018 Earnings Report

6 Followers

SNPHY Q1 2018 EPS Results

Actual EPS
$0.15
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$0.20

SNPHY Q1 2018 Revenue Results

Actual Revenue
$517.43M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q1 2018
Date
08/01/2018
Time
TBA
Conference Call
Wednesday, August 1, 2018
SNPHY Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q1 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

SNPHY Earnings History

SNPHY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q3)―-0.16――
Nov 05, 20262026 (Q2)―0.160.17-3.01% (-0.01)
Aug 06, 20262026 (Q1)―0.140.1216.67% (+0.02)
May 12, 20262025 (Q4)―0.310.1782.25% (+0.14)
Feb 05, 20262025 (Q3)―0.160.17-4.82% (-0.01)
Nov 06, 20252025 (Q2)―0.170.166.41% (+0.01)
Aug 07, 20252025 (Q1)―0.120.19-36.84% (-0.07)
May 13, 20252024 (Q4)―0.17016800.00% (+0.17)
Feb 06, 20252024 (Q3)―0.170.1418.57% (+0.03)
Nov 07, 20242024 (Q2)―0.160.17-8.24% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed